A
Acurx Pharmaceuticals D
D
ACXP
1.15000
USD
-0.14
(-10.85%)
Market Closed
Volume
2,016
EPS
-1
Div Yield
-
P/E
-1
Market Cap
19,426,430
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Acurx Pharmaceuticals
Sector: Healthcare
Industry: Biotechnology
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.